AMETEK, Inc. Q3 FY2025 earnings call

Management Statement and Operational Highlights

• AMETEK delivered outstanding Q3 results with double-digit growth in sales, orders, operating profit, and diluted earnings per share. Organic sales growth was strong, leading to margin expansion and earnings ahead of expectations.
• Recent acquisitions (FARO, Virtek, Kern, Paragon) are integrating well and delivering strong results.
• Invested $90 million in 2025 toward organic growth initiatives, focusing on R&D, sales, and digital marketing.
• Highlighted new product innovations: Virtek's AI-powered camera and software monitoring system, NSI's Vector Digital Receiver, and Rauland's Responder platform.
• Monitored global trade environment and executed mitigation plans like targeted pricing and supply chain modifications.

Segment Performance

• Electronic Instruments Group (EIG): Third quarter sales were a record $1.25 billion, up 10% from Q3 2024. Organic sales were flat, acquisitions added 9 points, and foreign currency was a 1-point tailwind. Operating income was $360 million, up 6% versus the prior year. Excluding recent acquisitions, operating margins were 30.4%, up 50 basis points versus the prior year.
• Electromechanical Group (EMG): Third quarter sales were a record $646 million, up 13% versus the prior year. Organic sales were up 12%, and foreign currency was a 1-point tailwind. Operating income was $164 million, up 25% compared to the prior year. Operating margins were up sharply to 25.4%, a 250 basis point increase from Q3 2024.

Guidance

• Full year sales expected to be up mid-single digits compared to 2024.
• Increased diluted earnings per share guidance for the year to $7.32-$7.37 (up from $7.06-$7.20).
• Q4 sales anticipated to be up approximately 10%, with earnings in the range of $1.90 to $1.95 per share.

Risks

• Macroscopic uncertainty, including ongoing trade conflicts and potential impact on demand timing.
• Potential effects of prolonged government shutdowns on business operations (if applicable).

Q: Could you tour key platforms and regions and discuss Paragon's performance?

A: Paragon had strong orders and sales. Process market sales up low teens, A&D organic sales up low double digits, Power & Industrial up mid-single digits. Paragon is in attractive medtech markets with good growth rates, restructuring ongoing to reduce cost structure, margins now in line with AMETEK's margins with more upside.

Q: Double-click on Paragon's organic sales and order growth and profitability vs. purchase view?

A: Paragon is in mid- to high single-digit growth markets, had outstanding double-digit orders, restructuring reducing cost structure, margins now in line with AMETEK's, expected to be 35-plus EBITDA business when restructuring done.

Q: Optimism on Process market, end markets and pent-up demand?

A: Process orders trending up in all areas except China, visibility improving, business leveraged to succeed with controlled cost structure and new product innovation, expected to do well in 2026.

Q: Strength in Europe, verticals and geographies?

A: Europe had low double-digit growth, strong in Dunkermotoren, Paragon, Materials Analysis, and Aerospace businesses.

Q: Order progression in Q4, organic, M&A, FX?

A: September was strongest month for sales and orders, acquisitions mid- to high single-digit, no FX impact on top or bottom line in Q4.

Q: Industrial & Power business organic growth, data center power tied?

A: Power side driving growth, including backup power systems, microgrids, solar racks, and nuclear industry, RTDS doing well with real-time simulations for grid expansion.

Q: FARO business organic trends, integration progress?

A: FARO hit sales and profit targets, integration going well, excellent strategic fit with AMETEK and Creaform, teams working on new products and channels.

Q: Process Industries orders, government shutdown effects?

A: Process orders trending up, government shutdown so far not a major issue, China part of business has academia research element but other areas trending up.

Q: Automation organic growth, end market color, customer demand?

A: Discrete automation strong, customers coming back, best products in sweet spot of precise equipment, seeing performance improvement after destock.

Q: EMG margins, Paragon's impact on EMG margins?

A: EMG margins strong, Paragon provides opportunity to increase margins further, target for next year to be set, expecting record margins going forward.

Q: Overall short-cycle exposure, M&A pipeline?

A: Business is mid-cycle, M&A pipeline strong, actively looking at high-quality deals, disciplined with returns on capital, teams active on deals.